Epstein-barr Virus Infection
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-22Clinical Trial Results: Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults [Phase 1]
Phase 1 trial evaluating safety and immunogenicity of an Epstein-Barr Virus gp350-Ferritin nanoparticle vaccine in healthy adults has comple…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons [Phase 1, Phase 2]
This trial update reports on the immunogenicity and safety of an adjuvanted Epstein-Barr virus glycoprotein 350 vaccine evaluated in EBV-ser…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Environmental Risk Factors in Multiple Sclerosis Development: Epidemiological Study of EBV Infection and Vitamin D Deficiency in RIS Patients
This completed clinical trial investigates environmental risk factors for developing multiple sclerosis in radiologically isolated syndrome …
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients
EVITA is a completed study monitoring Epstein-Barr virus infection in renal transplant recipients; the snippet does not include trial result…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection [Phase 1]
Phase 1 trial assessing safety and immunogenicity of an Epstein-Barr virus gp350-Ferritin nanoparticle vaccine in healthy adults with or wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) [Phase 1]
This is a Phase 1 trial update reporting completion of a study evaluating allogeneic multivirus-directed cytotoxic T lymphocytes for Epstein…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® [Phase 2]
Phase 2 study evaluating the safety and feasibility of infusing donor-derived virus-specific T cells for post-transplant viral infections in…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating donor-derived T lymphocytes for infections caused by adenovirus, cytomegalovirus, Epstein-Barr virus,…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients
A completed clinical trial evaluated the performance of the NeuMoDx EBV Quant Assay 2.0 in immunocompromised transplant patients with Epstei…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reports termination of a Phase 2/Phase 3 study of posoleucel (ALVR105, Viralym-M) for multi-virus prevention in patien…
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV [Phase 3]
Phase 3 trial updating PD-1 antibody plus lenalidomide for EBV-related diseases is underway, status not yet disclosed.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy [Phase 4]
A Phase 4 clinical trial update investigating a PD-1 monoclonal antibody as first-line therapy for EBV-related hemophagocytic lymphohistiocy…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma [Phase 1]
Phase Ib trial evaluating the MVA-EBNA1/LMP2 vaccine for nasopharyngeal carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus
This completed trial evaluated the effects of long-term valacyclovir (Valtrex) treatment on Epstein-Barr virus activity. The study included …
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Chronic Fatigue Following Acute Epstein-Barr Virus Infection in Adolescents
This update notes that a clinical trial examining chronic fatigue following acute Epstein-Barr virus infection in adolescents has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Differences Between Chidamide Taken Daily and Twice a Week in Therapeutic Effect，Pharmacokinetics, Pharmacodynamics and EB Virus Activation [Phase 2]
Phase 2 trial comparing daily versus twice-weekly dosing of chidamide and evaluating differences in therapeutic effect, pharmacokinetics/pha…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors [EARLY_Phase 1]
Early-phase 1 clinical trial update for nelfinavir in gammaherpesvirus-related tumors, noting termination of the study despite investigation…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) [Phase 1, Phase 2]
This clinical trial update covers Phase 1/2 testing of allogeneic virus-specific cytotoxic T-lymphocytes for adenovirus and Epstein-Barr vir…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
Completed retrospective chart review evaluating the antiviral supplement Gene-Eden-VIR/Novirin across multiple viral infections to assess ou…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients
This completed clinical trial evaluated Epstein-Barr virus infections as a risk factor for post-transplant lymphoproliferative disorder in p…
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) [Phase 1]
Phase 1 trial update on VIRAGE, rapidly generated multivirus-specific cytotoxic T-lymphocytes, for viral infections in the context of stem c…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes following a CD45 antibody in patients with EBV-positive nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2011-10-28Clinical Trial Update: Surveillance Study of Viral Infections Following Lung Transplantation
Completed surveillance trial examining viral infections in lung transplant recipients, including Epstein-Barr virus and paramyxoviridae infe…
-
CLINICAL_TRIALS trial_result · 2007-02-02Clinical Trial Update: Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664). [Phase 2]
Phase 2 trial update evaluating safety, immune response, and efficacy of GSK's Epstein-Barr virus vaccine in Epstein-Barr virus infection.